These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 3133978

  • 1. Serum antibodies to gangliosides in Guillain-Barré syndrome.
    Ilyas AA, Willison HJ, Quarles RH, Jungalwala FB, Cornblath DR, Trapp BD, Griffin DE, Griffin JW, McKhann GM.
    Ann Neurol; 1988 May; 23(5):440-7. PubMed ID: 3133978
    [Abstract] [Full Text] [Related]

  • 2. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C, Vial C, Bancel J, Petiot P, Antoine JC, Gonnaud PM.
    Ann Biol Clin (Paris); 2002 May; 60(5):589-97. PubMed ID: 12368145
    [Abstract] [Full Text] [Related]

  • 3. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K, Kamakura K, Ogawa G, Ueda M, Motoyoshi K, Arita M, Kusunoki S.
    Neurology; 2008 Jul 15; 71(3):196-201. PubMed ID: 18625966
    [Abstract] [Full Text] [Related]

  • 4. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome.
    Kusunoki S, Chiba A, Kon K, Ando S, Arisawa K, Tate A, Kanazawa I.
    Ann Neurol; 1994 May 15; 35(5):570-6. PubMed ID: 8179303
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C, Vial C, Petiot P, Bancel J, Later R, Gonnaud PM.
    Ann Biol Clin (Paris); 1999 May 15; 57(5):579-88. PubMed ID: 10518060
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M, Koga M, Gilbert M, Odaka M, Hirata K, Kuwabara S, Yuki N.
    J Neuroimmunol; 2006 Aug 15; 177(1-2):201-8. PubMed ID: 16844234
    [Abstract] [Full Text] [Related]

  • 9. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL.
    Ann Neurol; 1993 Aug 15; 34(2):130-5. PubMed ID: 8338337
    [Abstract] [Full Text] [Related]

  • 10. [Antiganglioside antibodies: when, which and for what].
    Gallardo E, Rojas-García R, Belvís R, Serrano-Munuera C, Ortiz E, Ortiz N, Grau J, Illa I.
    Neurologia; 2001 Aug 15; 16(7):293-7. PubMed ID: 11485721
    [Abstract] [Full Text] [Related]

  • 11. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M, Suzuki S, Takada K, Kusunoki S.
    J Neuroimmunol; 2011 Oct 28; 239(1-2):87-90. PubMed ID: 21914557
    [Abstract] [Full Text] [Related]

  • 12. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA, Koblar S, Hughes RA.
    Q J Med; 1993 Feb 28; 86(2):111-7. PubMed ID: 8464986
    [Abstract] [Full Text] [Related]

  • 13. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders.
    Kusunoki S, Kaida K.
    J Neurochem; 2011 Mar 28; 116(5):828-32. PubMed ID: 21214559
    [Abstract] [Full Text] [Related]

  • 14. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, Hirakawa M, Kusunoki S.
    J Neuroimmunol; 2007 Jan 28; 182(1-2):212-8. PubMed ID: 17113161
    [Abstract] [Full Text] [Related]

  • 15. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies].
    Kusunoki S.
    Rinsho Shinkeigaku; 1999 Jan 28; 39(1):93-5. PubMed ID: 10377820
    [Abstract] [Full Text] [Related]

  • 16. Anti-GD1a ganglioside antibodies in peripheral motor syndromes.
    Carpo M, Nobile-Orazio E, Meucci N, Gamba M, Barbieri S, Allaria S, Scarlato G.
    Ann Neurol; 1996 Apr 28; 39(4):539-43. PubMed ID: 8619533
    [Abstract] [Full Text] [Related]

  • 17. Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome.
    Ilyas AA, Cook SD, Mithen FA, Taki T, Kasama T, Handa S, Hamasaki H, Singhal BS, Li SC, Li YT.
    J Neuroimmunol; 1998 Mar 01; 82(2):160-7. PubMed ID: 9585812
    [Abstract] [Full Text] [Related]

  • 18. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA, Chen ZW, Cook SD, Mithen FA, Singhal BS.
    Res Commun Mol Pathol Pharmacol; 2001 Jul 01; 109(1-2):115-23. PubMed ID: 11458979
    [Abstract] [Full Text] [Related]

  • 19. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
    Nobile-Orazio E, Giannotta C, Briani C.
    J Neuroimmunol; 2010 Feb 26; 219(1-2):119-22. PubMed ID: 20006388
    [Abstract] [Full Text] [Related]

  • 20. Ganglioside complexes as new target antigens in Guillain-Barré syndrome.
    Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, Hirakawa M, Kusunoki S.
    Ann Neurol; 2004 Oct 26; 56(4):567-71. PubMed ID: 15389898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.